References
- Kirkwood BR, Gove S, Rogers S, Lob-Levyt J, Arthur P, Campbell H. Potential interventions for the prevention of childhood pneumonia in developing countries: a systematic review. Bull World Health Org 1995; 73: 793–8.
- Finch RG. Epidemiological features and chemotherapy of community-acquired respiratory tract infections. J Antimicrob Chemother 1990; Suppl E: 53–61.
- Marrie TJ. Community-acquired pneumonia in the elderly. Clin Infect Dis 2000; 31: 1066–78.
- Marrie TJ. Community-acquired pneumonia: epidemiology, etiology, treatment. Infect Dis Clin North Am 1998; 12: 723–40.
- Feldman C. Pneumonia in the elderly. Med Clin North Am 2001; 85: 1441–59.
- Gleckman RA, Bergman MM. Bacterial pneumonia: specific diagnosis and treatment of the elderly. Geriatrics 1987; 42: 29–36, 41.
- Bochud PY, Moser F, Erard P et al. Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) 2001; 80: 75–87.
- Brown PD, Lerner SA. Community-acquired pneumonia. Lancet 1998; 352: 1295–302.
- Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618–24.
- Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994; 18: 501–15.
- Kovacs JA, Gill VJ, Meshnick S, Masur H. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001; 286: 2450–60.
- Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998; 26: 811–38.
- Bauer T, Ewig S, Marcos MA, Schultze-Werninghaus G, Torres A. Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance? Med Clin North Am 2001; 85: 1367–79.
- Gross PA. Vaccines for pneumonia and new antiviral therapies. Med Clin North Am 2001; 85: 1531–44.
- Rappuoli R. Conjugates and reverse vaccinology to eliminate bacterial meningitis. Vaccine 2001; 19 (17–19): 2319–22.
- Lindberg AA. Glycoprotein conjugate vaccines. Vaccine 1999; 17 (Suppl 2): S28–36.